Bone marrow aspirate Cit-H3 was identified as a novel biomarker of minimal residual disease in neuroblastoma
Open Access
- 26 November 2025
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1)
Abstract
Background: Neuroblastoma (NB) is the most prevalent extracranial solid tumor in children. Neutrophils release neutrophil extracellular traps (NETs) following intense or prolonged activation. Neutrophil elastase (ELA2) and citrullinated histone H3 (Cit-H3) are specific markers of NETs. Additionally, neuron-specific enolase (NSE) serves as a biomarker and can be used to monitor the condition of NB progression, assess treatment response, and predict recurrence. Methods: This study employed a retrospective study design, and all samples were collected prior to bone marrow aspiration for diagnosis. A total of 39 serum samples from patients diagnosed with NB by postoperative pathological bone marrow aspiration were included as the study subjects, and neutrophils, ELA2, and Cit-H3 were detected in the study subjects using ELISA. The blood routine data of 99 patients diagnosed with NB were collected, and these data were from patients different from those of the aforementioned 39 serum samples. And patients were divided into two groups, namely NB patients with positive bone marrow metastasis and those without metastasis, based on the result of bone marrow GD2 immunohistochemical staining. All data were statistically analyzed using IBM SPSS Statistics 26.0 and GraphPad Prism 9.0 software. Results: A positive correlation was identified between NB bone marrow minimal residual disease (MRD) positivity and haematological indices, including interleukin-2 (IL-2) ( p = 0.021), IL-6 ( p = 0.030), NSE ( p < 0.001), and Cit-H3 ( p < 0.001). And MRD was positively associated with blood neutrophils in bone marrow ( p < 0.05). Conclusions: This study demonstrates a significant correlation between NETs and MRDs, and found a positive correlation between bone marrow MRD + and the indicators of IL-2, IL-6, and NSE, as well as a positive correlation with bone marrow neutrophils. And Cit-H3 was identified as a new biomarker and found a positive correlation between Cit-H3 and bone marrow MRD + .Keywords
Funding Information
- National Natural Science Foundation of China (No. 82202595)
- Tianjin Municipal Education Commission (No. 2021KJ262)
- Tianjin Health Research Project (No. TJWJ2021MS010)
This publication has 38 references indexed in Scilit:
- Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapyCytokine & Growth Factor Reviews, 2025
- Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancerImmunity, 2024
- A nomogram for predicting recurrence-free survival of intermediate and high-risk neuroblastomaEuropean Journal of Pediatrics, 2022
- Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunityCancer Cell, 2022
- Mac-1 triggers neutrophil DNA extracellular trap formation to Aspergillus fumigatus independently of PAD4 histone citrullinationJournal of Leukocyte Biology, 2019
- Circulating tumor DNA in blood: Future genomic biomarkers for cancer detectionExperimental Hematology, 2018
- Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects2015
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancersPharmacology & Therapeutics, 2014
- Rapid killing of human neutrophils by the potent activator phorbol 12-myristate 13-acetate (PMA) accompanied by changes different from typical apoptosis or necrosisJournal of Leukocyte Biology, 1996
- Serum neuron‐specific enolase in children with neuroblastoma. Crelationship to stage and disease courseCancer, 1986